This next-generation sequencing assay targets 7 Mb of the genome, covering 740 genes.  These genes were selected following manual review of the cancer literature, and also includes genes from 6 publicly available cancer databases, as well as genes which have been included in 7 commercial panels.  

The Xplora cancer panel test is validated according to CAP guideline for fresh frozen samples. It is intended for basic research and clinical research use only, for applications such as biomarker screening, development of companion diagnostics, as well as development of focused disease panel tests.  

Please email us for more information.